Cargando…
Imbalanced expression of cation-chloride cotransporters as a potential therapeutic target in an Angelman syndrome mouse model
Angelman syndrome is a neurodevelopmental disorder caused by loss of function of the maternally expressed UBE3A gene. Treatments for the main manifestations, including cognitive dysfunction or epilepsy, are still under development. Recently, the Cl(−) importer Na(+)-K(+)-Cl(−) cotransporter 1 (NKCC1...
Autores principales: | Egawa, Kiyoshi, Watanabe, Miho, Shiraishi, Hideaki, Sato, Daisuke, Takahashi, Yukitoshi, Nishio, Saori, Fukuda, Atsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110603/ https://www.ncbi.nlm.nih.gov/pubmed/37069177 http://dx.doi.org/10.1038/s41598-023-32376-z |
Ejemplares similares
-
Short-latency somatosensory-evoked potentials demonstrate cortical dysfunction in patients with Angelman syndrome
por: Egawa, Kiyoshi, et al.
Publicado: (2020) -
Structural Pharmacology of Cation-Chloride Cotransporters
por: Zhao, Yongxiang, et al.
Publicado: (2022) -
Role of the Cation-Chloride-Cotransporters in Cardiovascular Disease
por: Meor Azlan, Nur Farah, et al.
Publicado: (2020) -
Role of the cation-chloride-cotransporters in the circadian system
por: Salihu, Shihan, et al.
Publicado: (2021) -
Pharmacological inhibition of cation-chloride cotransporters for neurological diseases
por: Nepomuceno, Rachel, et al.
Publicado: (2015)